Skip to content
OpenCapital
Get started

KALA BIO, Inc. KALA Q4 2024 Annual earnings

Reported March 31, 2025 · Before market open

Revenue$254.0K
EPS-$1.74Beat by $0.54
EPS estimate-$2.28

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$6.00

Versus estimates

Revenue

Q4 2024$254.0K

Diluted EPS

Q1 2026-$0.14Beat by $8.36Q4 2025$0.02Beat by $0.34Q3 2025-$1.07Miss by $0.06Q2 2025-$1.71Beat by $0.11Q1 2025-$1.41Beat by $0.62
Q4 2024-$1.74Beat by $0.54

Ask the moment KALA BIO, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did KALA BIO, Inc. report Q4 2024 earnings?
KALA BIO, Inc. (KALA) reported Q4 2024 earnings on March 31, 2025 before market open.
What were KALA BIO, Inc.'s Q4 2024 revenue and EPS?
KALA BIO, Inc. reported revenue of $254.0K and eps of $-1.74 for Q4 2024.
Did KALA BIO, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-2.28 by $0.54.
Where can I find KALA BIO, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-004081) directly on SEC EDGAR. The filing index links above go to sec.gov.